Physician profile
Brian Solberg
NPI 1396729216
$2,413.67
in general payments reported to CMS, 2019-2025
10 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.82 · 2020: $155 · 2021: $230 · 2022: $195 · 2023: $169 · 2024: $411 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,935.51 | 2020-2025 | Mako, Triathlon, Insignia |
| Integra Lifesciences Corporation | $101.06 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Saxum Surgical, INC. | $91.85 | 2023-2024 | |
| Smith+Nephew, INC. | $70.00 | 2022-2023 | Pico 7 |
| Ethicon US, LLC | $52.21 | 2020 | |
| Bioventus LLC | $48.69 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $42.57 | 2019-2021 | |
| Linvatec Corporation | $35.28 | 2025 | Biobrace 23mm |
| Merck Sharp & Dohme LLC | $21.41 | 2022 | |
| Depuy Synthes Sales INC. | $15.09 | 2024 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Solberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.